Why is Epigenetics all about- detailing the genetics of the market

Epigenetics Market – Overview

Epigenetics gives the answer to the age old question of “Nature vs Nurture”, which lies at the core of why we what we do.

Nature versus Nurture is a term in psychology used to differentiate between heredity or the environment, which impacts the human psychological development more.

Some scientists contend that the persona of a person is based on the genetics inherited from one’s parents, while some claim that it is also based on the surroundings and life experiences in which the person grows up in.

While scientists have understood that the interfaces between environment and genes shape up the nature of a person, but it was not until recently that they have begun to pinpoint the mechanism of gene interfaces with the environment.

This mechanism is called Epigenetics.

Epigenetics is the missing bond which connects the Nature and Nurture aspect of the personality of a living being.

Epigenetics can soon be accredited to answer questions of the likes of

  • Will Cristiano Ronaldo’s children be as good as him in football? If yes, is it because they share a common super gene which makes them the best at playing football or is it because his children grew up in an environment where his children also start to love the sport like their father? Epigenetics hopes to provide an explanation for the same.

All about Epigenetics

According to the Roadmap Epigenetics Project, Epigenetics refers to both heritable changes in gene expression and activity (in the progeny of individuals or of cells) and also stable, long-term changes in the transcriptional potential of a cell that are not necessarily genetic. Epigenetics refers to the study of single genes or sets of genes, whereas epigenomics refers to more global analyses of epigenetic changes across the entire genome.

Epigenetics as a field has huge medical uses and thorough research in this field has produced great understandings. The Epigenomic state is objectively regulated and it is observed that any misregulations of epigenetic patterns are observed in many human ailments and types of cancers. Variations in epigenomes are also considered to be related to the aging process. A great deal of genetic disorders are anticipated to have epigenetic transformations. These include the likes of Prader-Willi Syndrome, Angelman Syndrome, Rett Syndrome and a few others. Epigenetic mechanisms are also apparent in major diseases such as Autoimmune Diseases, Cancer, Diabetes, and Mental disorders.

The advent of new data in relation to epigenetics obtained in the recent years is a strong indication of the future of the Epigenetics research and the scope a market will hold for epigenetic technologies. The ever swelling data availability of epigenetic marks and the growing database of epigenetic marks will encourage more research and attract huge investments and funding. The research will help in gathering more insights on various tissues, stages of development and various states of the disease. Further, based on the research, tools can be developed to diagnose the patients and assess the severity of the disease.

Epigenetics market disrupting largely due to the fact that various diseases can be looked at from a new perspective and the treatment processes can be formulated. The fact that Epigenetic controls are lucrative therapeutic targets because their involvement in the reversibility of many human diseases, which gives us a lot of hope.

The most recent developments include the use of Epigenetic expertise as the basis of many cancer treatments. Epigenetics is also being used to indicate the presence or future development of disease. This is highly vital in the growth of personalized medicine and may also allow the early discovery of patients at bigger threat of disease.

The Global Epigenetics Market

The market is on an upsurge considering the huge potential it offers in terms of providing remedies for like threatening diseases and ailments.

The Global market for Epigenetics is considered to be valued at $533.46 million for the year 2017 and is poised to reach $1.009 billion by the end of 2022.

Some of the factors like rising prevalence of cancer, increasing funding in R&D, and increasing frequency of research activities are driving the growth of the market. However, lack of trained professionals and high cost of instruments are some of the factors restraining the market.

Major players in the global epigenetics market are Abcam plc., Illumina, Inc., QIAGEN N.V., Merck & Co., New England Biolabs, Inc., Sigma-Aldrich Corporation, Thermo Fisher Scientific, Inc., Active Motif, Diagenode, Inc. and Zymo Research Corporation.   

Check out Market Data Forecast’s comprehensive reports with in-depth analysis about the Epigenetics Market a free research sample can also be availed. Stay tuned for trending news stories about the latest technologies and interesting Healthcare tit-bits.

Share this post:

Recent Posts

Leave a Comment